Pradaxa label updated with contraindication
The anticoagulant dabigatran etexilate mesylate should not be used in patients with mechanical prosthetic heart valves, the FDA warns.
Diagnosis & Disease Information
Fatal skin reactions reported with hep C drug
A boxed warning about potentially fatal skin reactions will be added to the oral hepatitis C drug telaprevir.
Alcohol contraindicated with Xyrem
The FDA is warning against taking sodium oxybate with alcohol or CNS depressant drugs, due to increased risk for impaired consciousness and respiratory distress.
Heparin labels updated to clarify drug strength
Heparin label changes eliminate the need for clinicians to calculate the total amount of heparin medication in a product containing more than 1 mL.
Fungal meningitis death toll hits 20
Health officials have confirmed the presence of the fungus Exserohilum rostratum in unopened recalled steroid vials from New England Compounding Pharmacy.
Cases, deaths continue to rise in fungal meningitis outbreak
Although no new exposures to contaminated meds are likely, the CDC is urging clinicians to remain on the look out for new cases in the coming weeks.
FDA issues new safety measures for opioid meds
The FDA has approved a risk evaluation and mitigation strategy (REMS) for extended-release (ER) and long-acting (LA) opioids.
FDA prompts removal of unapproved oxycodone products
The FDA has issued a Federal Register notice instructing companies to stop manufacturing and distributing certain unapproved drugs that contain oxycodone.
Mixing herbal and prescription meds
Patients often consider supplements and herbs harmless, but combining them with other drugs can have devastating consequences.
Dietary supplement contains unlabeled meds
The FDA is warning against using Reumofan Plus, a Mexican product marketed as a “natural” dietary supplement for pain relief, because it may contain unlabeled, potentially harmful pharmaceuticals.
- Loading...
Loading...
Next post in Web Exclusives
Loading... 
Loading...